George Emile - Concepedia

Author

George Emile

Centre François Baclesse ORCID

Also Known As

G Emile, G. Emile, G.A. Emile, GEORGE EMILE, George EMILE, George Emile

Publications

697

Citations

H-Index

Concepts

All Affiliations

Centre François Baclesse Inserm Centre Antoine Lacassagne Centre Eugène Marquis Centre Henri Becquerel

About

George Emile is an author at Centre François Baclesse specializing in medicine, health sciences, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	191
2	Health Sciences	2	2	168
3	Pathology	2	2	168
4	Cancer Therapeutics	2	2	180
5	Obstetrics	1	1	23

George Emile

Publications

596

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer François‐Clément Bidard, William Jacot, Nicolas Kiavué, JAMA Oncology	2020	168
Genomics to select treatment for patients with metastatic breast cancer Fabrice André, Thomas Filleron, Maud Kamal, Nature Metastatic Breast CancerBreast OncologyTumor HeterogeneityMedicinePathology	2022	157
Impact of body mass index on overall survival in patients with metastatic breast cancer Khalil Saleh, Matthieu Carton, Véronique Dièras, The Breast	2020	47
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer Florian Clatot, Anne Perdrix, Ludivine Beaussire, Breast Cancer Research	2020	37
Comparison of Management and Outcomes in <i>ERBB2</i>-Low vs <i>ERBB2</i>-Zero Metastatic Breast Cancer in France Ombline de Calbiac, Amélie Lusque, Audrey Mailliez, JAMA Network Open	2022	34
A clinical experience of single agent bevacizumab in relapsing ovarian cancer George Emile, L. Chauvenet, Jean‐Marie Tigaud, Gynecologic Oncology Single Agent BevacizumabMedicineCancer ManagementGynecologyCancer Treatment	2013	23
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib George Emile, Sarah Penager, Christelle Lévy, Oncology Letters	2021	21
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer François Cherifi, Angélique Da Silva, Alison Johnson, BMC Cancer	2022	20
Sleep macro- and microstructure in breast cancer survivors Joy Perrier, Mylène Duivon, Patrice Clochon, Scientific Reports	2022	16
The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer Jordane Divoux, Romane Florent, M.J. Jacobs, BMC Cancer	2023	16

Page 1